CHI's CEO and co-founder, David Harris, will be speaking at the Global Rescon Summit in Portugal this coming November about CHI's Aeolus technology in a presentation titled: 'Using a Fluidic Gearbox to Improve Respiratory Drug Delivery'.
Global Rescon is a leading conference for respiratory drug delivery and connected devices and 2026 marks its fourth year, having previously been held in New York, Barcelona, and San Francisco. This year's event takes place in Porto on the 10th and 11th of November. Further information can be found here: https://rescon-europe.com/.
According to the orgnaisers, the event "showcases cutting-edge innovations, emerging technologies, and strategic insights across the full respiratory and drug delivery spectrum — including sustainable inhaler design, advanced plastics and material science, combination products, nebulization technologies, spray drying for inhaled biologics, digital health integration, regulatory expectations, and next-generation therapeutic platforms."
